Table 2 Treatment outcomes of TB patients in JGH (July 2004–June 2014)
Characteristics | Number (%) stratified by the treatment outcomes | Total N (%) | P value | |||||
|---|---|---|---|---|---|---|---|---|
Successful treatment outcomes 868 (74) | Unsuccessful treatment outcomes 304 (24) | |||||||
Cured | Treatment completed | Died | T. failurea | Loss to follow-up | Interrupter | |||
Sex | ||||||||
Female | 66 (14.2) | 299 (64.3) | 40 (8.6) | 0 (0.0) | 30 (6.5) | 30 (6.5) | 465 (39.7) | 0.059 |
Male | 88 (12.4) | 415 (58.7) | 79 (11.2) | 1 (0.1) | 77 (10.9) | 47 (6.6) | 707 (60.3) | |
Age in years | ||||||||
< 15 | 5 (3.4) | 101 (69.7) | 10 (6.9) | 0 (0.0) | 8 (5.5) | 21 (14.5) | 145 (12.4) | < 0.001 |
15–24 | 55 (21.7) | 145 (57.1) | 19 (7.5) | 0 (0.0) | 22 (8.7) | 13 (5.1) | 254 (21.7) | |
25–34 | 56 (15.3) | 216 (59.2) | 39 (10.7) | 1 (0.3) | 34 (9.3) | 19 (5.2) | 365 (31.1) | |
35–44 | 23 (10.6) | 138 (63.3) | 24 (11.0) | 0 (0.0) | 22 (10.1) | 11 (5.0) | 218 (18.6) | |
45–54 | 10 (10.4) | 50 (52.1) | 16 (16.7) | 0 (0.0) | 12 (12.5) | 8 (8.3) | 96 (8.2) | |
≥ 55 | 5 (5.3) | 64 (68.1) | 11 (11.7) | 0 (0.0) | 9 (9.6) | 5 (5.3) | 94 (8.0) | |
TB patients category | ||||||||
New TB cases | 125 (12.0) | 633 (61.0) | 107 (10.3) | 0 (0.0) | 98 (9.4) | 75 (7.2) | 1038 (88.6) | < 0.001 |
Re-treatment TB cases | 16 (30.2) | 22 (51.2) | 5 (11.6) | 0 (0.0) | 3 (7.0) | 0 (0.0) | 43 (3.7) | |
Transfer-in TB cases | 13 (27.7) | 30 (63.8) | 1 (2.1) | 0 (0.0) | 2 (4.3) | 1 (2.1) | 47 (4.0) | |
Type of TB | ||||||||
PTB− | NA | 436 (71.5) | 72 (11.8) | NA | 51 (8.4) | 51 (8.4) | 610 (52.0) | < 0.001 |
PTB+ | 154 (54.8) | 73 (26.0) | 24 (8.5) | 1 (0.4) | 22 (7.8) | 7 (2.5) | 281 (24.0) | |
EPTB | NA | 205 (73.0) | 23 (8.2) | NA | 34 (12.1) | 19 (6.8) | 281 (24.0) | |
HIV test result | ||||||||
Non reactive | 81 (15.1) | 341 (63.7) | 29 (5.4) | 0 (0.0) | 39 (7.3) | 45 (8.4) | 535 (45.6) | < 0.001 |
Reactive | 28 (11.9) | 138 (58.7) | 41 (17.4) | 0 (0.0) | 15 (6.4) | 13 (5ρ.5) | 235 (20.1) | |
Unknown | 45 (11.2) | 235 (58.5) | 49 (12.2) | 1 (0.2) | 53 (13.2) | 19 (4.7) | 402 (34.3) | |
Year of TB treatment | ||||||||
July 2004–June 2005 | 10 (12.2) | 43 (52.4) | 14 (17.1) | 1 (1.2) | 13 (15.9) | 1 (1.2) | 82 (7.0) | < 0.001 |
July 2005–June 2006 | 9 (8.3) | 63 (57.8) | 21 (19.3) | 0 (0.0) | 15 (13.8) | 1 (0.9) | 109 (9.3) | |
July 2006–June 2007 | 13 (8.9) | 91 (62.3) | 11 (7.5) | 0 (0.0) | 21 (14.40) | 10 (6.8) | 146 (12.5) | |
July 2007–June 2008 | 18 (11.8) | 101 (66.0) | 19 (12.4) | 0 (0.0) | 10 (6.5) | 5 (3.3) | 153 (13.1) | |
July 2008–June 2009 | 20 (16.3) | 83 (67.5) | 11 (8.9) | 0 (0.0) | 4 (3.3) | 5 (4.1) | 123 (10.5) | |
July 2009–June 2010 | 19 (13.7) | 92 (66.2) | 12 (8.6) | 0 (0.0) | 12 (8.6) | 4 (2.9) | 139 (11.9) | |
July 2010–June 2011 | 21 (11.7) | 120 (67.0) | 8 (4.5) | 0 (0.0) | 8 (4.5) | 22 (12.3) | 179 (15.3) | |
July 2011–June 2012 | 15 (14.3) | 57 (54.3) | 6 (5.7) | 0 (0.0) | 8 (7.6) | 19 (18.1) | 105 (9.0) | |
July 2012–June 2013 | 19 (30.2) | 34 (54.0) | 6 (9.5) | 0 (0.0) | 1 (1.6) | 3 (4.8) | 63 (5.4) | |
July 2013–June 2014 | 10 (13.7) | 30 (41.1) | 11 (15.1) | 0 (0.0) | 15 (20.5) | 7 (9.6) | 73 (6.2) | |
Total | 154 (13.1) | 714 (60.9) | 119 (10.2) | 1 (0.1) | 107 (9.1) | 77 (6.6) | 1172 (100) | |